Gastroenterology clinical trials recruiting in New York

32 recruiting gastroenterology trials match in New York. Showing 20.

• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 / Phase 3 · Janssen Research & Development, LLC · Carmel, New York

• LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:Recruiting

  Phase 2 · Eli Lilly and Company · Utica, New York

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)Recruiting

  Phase 3 · Eli Lilly and Company · Buffalo, New York

• A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Sanofi · Maspeth, New York

• A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's DiseaseRecruiting

  Phase 3 · Takeda · Colorado Springs, Colorado

• LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisRecruiting

  Phase 3 · Boehringer Ingelheim · Brooklyn, New York

• A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Janssen Research & Development, LLC · New York, New York

• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightRecruiting

  Phase 3 · Eli Lilly and Company · New York, New York

• Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)Recruiting

  Phase 3 · Merck Sharp & Dohme LLC · New York, New York

• BOOM-IBD2 Pivotal Clinical TrialRecruiting

  N/A · Boomerang Medical · Manhasset, New York

• Zymfentra (Infliximab-dyyb) REal World Cohort STudyRecruiting

  N/A · University of North Carolina, Chapel Hill · New York, New York

• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)Recruiting

  Phase 3 · Takeda · New Hyde Park, New York

• A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's DiseaseRecruiting

  Phase 3 · Eli Lilly and Company · New York, New York

• A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 3 · Janssen Research & Development, LLC · Carmel, New York

• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver FibrosisRecruiting

  Phase 3 · Boehringer Ingelheim · Brooklyn, New York

• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 3 · Sanofi · Maspeth, New York

• Behavioral Therapy for Crohn's DiseaseRecruiting

  N/A · Icahn School of Medicine at Mount Sinai · New York, New York

• Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)Recruiting

  N/A · Northwestern University · Syracuse, New York

• A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's DiseaseRecruiting

  Phase 3 · Takeda · Orange, California

• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)Recruiting

  Phase 3 · Merck Sharp & Dohme LLC · Great Neck, New York

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.